Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c07fc85adfac6f5bfe35e4839e490b4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 |
filingDate |
1994-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0706891c5b95d8b66fc73bd0825fec7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0941458345bf3dc00edfe58c6ba22467 |
publicationDate |
1994-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9426265-A1 |
titleOfInvention |
16-hydroxytriptolide composition and method for immunotherapy |
abstract |
A composition for use in immunosuppression therapy is disclosed. The composition includes an immunosuppressant drug, such as cyclosporin A and an amount of 16-hydroxytriptolide effective to potentiate the immunosuppressive effect of the immunosuppressant drug. The composition is particularly useful for in treating transplantation rejection or autoimmune disease. Also disclosed is a method of immunosuppression that includes administering to a subject (i) a pharmaceutically effective amount of an immunosuppressant drug and (ii) purified 16-hydroxytriptolide in an amount effective to potentiate the action of the drug. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662976-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306900-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863464-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1722806-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7847109-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617906-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11713487-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1722806-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020224271-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6172107-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2583678-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5849730-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8426616-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-741209-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5972998-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9852933-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8193249-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6025391-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6329148-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820834-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7557139-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6004999-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8048914-B2 |
priorityDate |
1993-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |